PRLD · Prelude Therapeutics Inc · Investor Relations
$3.23
-0.03 (-0.77%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2025 earnings call transcript
Market Cap
$258.63M
Shares
80.07M
Volume · Nov 20
300.1K
Avg daily vol (3M)
434.45K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-12-02 12:55 UTC | 9th Annual Evercore Healthcare Conference | Conference |
Recent news
Past events
| Date | Event | Type |
|---|---|---|
| 2026-10-20 | Chardan Healthcare Conference | Conference |
| 2026-09-16 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-03 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-03-10 | Citizens Life Sciences Conference 2026 | Conference |
| 2025-11-12 | Prelude Therapeutics Third Quarter 2025 Financial Results Conference Call | Earnings call |
| 2025-06-11 | Goldman Sachs 46th Annual Global Healthcare Conference | Conference |
| 2025-06-05 | 2025 Jefferies Global Healthcare Conference | Conference |
| 2025-05-07 | Citizens Life Sciences Conference | Conference |
| 2025-03-11 | Barclays 27th Annual Global Healthcare Conference | Conference |
| 2024-12-02 | The Citizens JMP Hematology and Oncology Summit | Webcast |
| 2024-09-13 | PRT3789 Phase 1 Interim Clinical Data Update from 2024 ESMO Congress | Event |
Source: https://preludetx.com/investors/
Key facts
CIK
1678660
CUSIP
74065P101
13F (30d)
104 filings
90 filers
Visit website
Investor relations